What needs to happen before a COVID vaccine for kids is authorized


As the race to develop a COVID-19 vaccine for children under 12 continues, patiently-waiting parents who are hungry for answers might try keeping an eye out for a few notable signs of progress, writes The Atlantic.
The first "milestone" will be reached when under-12 vaccine trials stop accepting new participants, notes The Atlantic; after that, researchers "can put all their effort into evaluating the trial itself." As of Wednesday, both Pfizer and Moderna's trials were reportedly still listed as "recruiting" in the National Library of Medicine's clinical-trial database. For context, Pfizer submitted an FDA application for its adolescent vaccine iteration just over two months after closing trial enrollment.
The next and more obvious milestone would be reached when either manufacturer submits an emergency use authorization application. Then, in the case of Pfizer, the company's 12-to-15-year-old EUA was approved a month after its submission.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
However, late last month, Pfizer and Moderna both extended the recruitment phrases for their under-12 vaccine clinical trials. The FDA, which requested the extension, said it is concerned about "having a large-enough sample size to detect rare side effects," writes The Atlantic. It is unclear how much time the extra recruiting will take.
So, in the meantime, the best way to protect young children continues to be "masking, quality ventilation, frequent testing, and vaccinating as many adults and adolescents as possible," writes The Atlantic.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
The week's best photos
In Pictures A tomato fight, painting behind bars, and more
-
Mountainhead: Jesse Armstrong's tech bro satire sparkles with 'weapons-grade zingers'
The Week Recommends The Succession creator's first feature film lacks the hit TV show's 'dramatic richness' – but makes for a horribly gripping watch
-
This Atlantic hurricane season is expected to be above average
Under the radar Prepare for strong storms in the coming months
-
Breakthrough gene-editing treatment saves baby
speed read KJ Muldoon was healed from a rare genetic condition
-
Sea lion proves animals can keep a beat
speed read A sea lion named Ronan beat a group of college students in a rhythmic dance-off, says new study
-
Humans heal much slower than other mammals
Speed Read Slower healing may have been an evolutionary trade-off when we shed fur for sweat glands
-
Novel 'bone collector' caterpillar wears its prey
Speed Read Hawaiian scientists discover a carnivorous caterpillar that decorates its shell with the body parts of dead insects
-
Scientists find hint of alien life on distant world
Speed Read NASA's James Webb Space Telescope has detected a possible signature of life on planet K2-18b
-
Katy Perry, Gayle King visit space on Bezos rocket
Speed Read Six well-known women went into lower orbit for 11 minutes
-
Scientists map miles of wiring in mouse brain
Speed Read Researchers have created the 'largest and most detailed wiring diagram of a mammalian brain to date,' said Nature
-
Scientists genetically revive extinct 'dire wolves'
Speed Read A 'de-extinction' company has revived the species made popular by HBO's 'Game of Thrones'